Table 2.
Rheumatoid arthritis (n = 12) | Pre-diabetes mellitus (n = 9) | |||
---|---|---|---|---|
Pre-HIIT | Post-HIIT | Pre-HIIT | Post-HIIT | |
Skeletal muscle concentrations, pg/mL per μg | ||||
IL-1β | 0.007 (0.005) | 0.009 (0.006) | 0.011 (0.010) | 0.009 (0.006) |
IL-6 | 0.010 (0.006) | 0.013 (0.007) | 0.012 (0.006) | 0.017 (0.009) |
IL-8 | 0.112 (0.212) | 0.121 (0.168) | 0.052 (0.024) | 0.112 (0.081) |
TNF-α | 0.008 (0.007) | 0.012 (0.006) | 0.006 (0.004) | 0.009 (0.007) |
IL-10 | 0.009 (0.012) | 0.006 (0.004) | 0.005 (0.003) | 0.005 (0.004) |
Myostatin | 16.621 (7.463) | 20.589 (8.685) | 31.884 (14.34)* | 34.314 (20.08)* |
Plasma concentrations, ng/mL | ||||
Galectin-3 | 12.21 (6.72) | 11.99 (4.22) | 8.73 (2.31) | 8.71 (2.70) |
Sample skeletal muscle concentrations were normalized to initial masses. Continuous variable data are presented as mean (standard deviation). Abbreviations: HIIT high-intensity interval training, IL interleukin, TNF-α tumor necrosis factor-alpha
*P <0.05 for comparisons between rheumatoid arthritis and pre-diabetes mellitus groups